Table 1.
Patient | Gene | Transcript ID | Nucleotide | Amino acid | Zygosity | Inheritance | Classificationa | Disease |
---|---|---|---|---|---|---|---|---|
A | MYO6 | NM_004999.3 | c.1983+1G>A | p.? | hom | AR | Pathogenic | Deafness type 37 |
B | CLN6 | NM_017882.2 | c.[697_705del];[c.13C>T] | p.[Leu233_Ile235del];[Arg5Trp] | comp.het | AR | Pathogenic | Ceroid lipofuscinosis neuronal type 6 |
C | KCTD7 | NM_001167961.2 | c.422T>C | p.Leu141Pro | hom | AR | Likely Pathogenic | Ceroid lipofuscinosis neuronal type 14 |
D | LRBA | NM_006726.4 | c.3985_3986del | p.Asp1329Tyrfs*18 | hom | AR | Pathogenic | Immunodeficiency common variable 8 |
E | ARSB | NM_000046.3 | c.[310C>A];[928A>G] | p.[Gln104Lys];[Asn310Asp] | comp.het | AR | Likely Pathogenic | Mucopolysaccharidosis type VI |
hom = homozygous; comp.het = compound heterozygous; het = heterozygous; AR = autosomal recessive; AD = autosomal dominant; VUS = variant of uncertain significance.
following the ACMG 2015 guidelines.